Not Tagged
genmab
['genmab']
our versatile duobody platform technology is the basis of many of the #bispecific antibodies in our pipeline being investigated to treat various cancers. learn more about this unique technology: #ash22
We are a leader in harnessing the power of human antibodies and our purpose is to improve the lives of people with cancer | Disclaimer https://t.co/E8NokG2tvL